Cabot Corporation (NYSE:CBT) Receives $89.00 Consensus Target Price from Brokerages

Shares of Cabot Corporation (NYSE:CBT) have earned a consensus rating of “Hold” from the seven research firms that are currently covering the company, Marketbeat.com reports. One analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and two have assigned a buy recommendation to the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $89.00.

A number of equities analysts have weighed in on CBT shares. Truist Financial set a $100.00 price target on shares of Cabot in a report on Wednesday, August 5th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a report on Sunday, August 9th. UBS Group lowered their price target on Cabot from $97.00 to $92.00 and set a “neutral” rating for the company in a research report on Wednesday, August 5th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, Mizuho raised their price objective on Cabot from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Thursday, June 25th.

Cabot Stock Performance

Shares of CBT opened at $86.44 on Thursday. Cabot has a 1 year low of $58.33 and a 1 year high of $94.53. The company’s 50 day simple moving average is $88.20 and its 200 day simple moving average is $80.57. The company has a market capitalization of $4.46 billion, a price-to-earnings ratio of 24.35, a PEG ratio of 11.47 and a beta of 0.84. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.97 and a current ratio of 1.47.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Monday, August 3rd. The specialty chemicals company reported $1.67 earnings per share for the quarter, topping analysts’ consensus estimates of $1.66 by $0.01. Cabot had a return on equity of 20.29% and a net margin of 5.23%.The company had revenue of $982.00 million for the quarter, compared to analyst estimates of $943.16 million. During the same quarter in the prior year, the company posted $1.90 EPS. The business’s revenue for the quarter was up 6.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. On average, sell-side analysts predict that Cabot will post 6.33 EPS for the current year.

Cabot Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be issued a $0.4725 dividend. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a yield of 2.2%. Cabot’s dividend payout ratio (DPR) is presently 53.24%.

Insiders Place Their Bets

In other Cabot news, CEO Sean D. Keohane sold 91,923 shares of Cabot stock in a transaction that occurred on Friday, August 7th. The shares were sold at an average price of $86.41, for a total transaction of $7,943,066.43. Following the transaction, the chief executive officer directly owned 404,134 shares of the company’s stock, valued at $34,921,218.94. The trade was a 18.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. 3.08% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Cabot

A number of hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in Cabot in the 2nd quarter worth approximately $633,302,000. Fuller & Thaler Asset Management Inc. raised its stake in shares of Cabot by 5.6% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 2,343,322 shares of the specialty chemicals company’s stock valued at $155,315,000 after purchasing an additional 124,613 shares during the period. State Street Corp lifted its position in shares of Cabot by 1.0% during the fourth quarter. State Street Corp now owns 2,025,589 shares of the specialty chemicals company’s stock worth $134,256,000 after purchasing an additional 20,021 shares in the last quarter. Dimensional Fund Advisors LP lifted its position in shares of Cabot by 4.8% during the first quarter. Dimensional Fund Advisors LP now owns 1,742,782 shares of the specialty chemicals company’s stock worth $131,253,000 after purchasing an additional 79,499 shares in the last quarter. Finally, Bank of America Corp DE boosted its stake in shares of Cabot by 3.9% in the third quarter. Bank of America Corp DE now owns 1,683,520 shares of the specialty chemicals company’s stock valued at $128,032,000 after purchasing an additional 63,080 shares during the period. Hedge funds and other institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.